Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers / Bianchini, G; Pusztai, L; Karn, T; Iwamoto, T; Rody, A; Kelly, C; Müller, V; Schmidt, S; Qi, Y; Holtrich, U; Becker, S; Santarpia, L; Fasolo, A; Del Conte, G; Zambetti, M; Sotiriou, C; Haibe-Kains, B; Symmans, Wf; Gianni, L. - In: BREAST CANCER RESEARCH. - ISSN 1465-5411. - (2013).